Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
glaxosmithkline
vertex pharmaceuticals
abbvie
amgen
anemia
biogen
bristol-myers squibb
cancer
chinook therapeutics
covid-19
What
days
4
×
roundup
4
×
bio
ahead
biotech
cancer
abbvie’s
alliance
ambien
american
annual
asco
attendees
attention
august
biofourmis
bristol
bucks
busy
buy
calls
camp’s
cash
celebrate
chance
changing
chicago
city
clinical
color
combinations
community’s
corner
crispr
day
decisions
devices
drug
drugs
expanding
Language
unset
Current search:
roundup
×
days
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
